Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:40 2026-07-07 EDT			5-day change	1st Jan Change
7.870 ^HKD	-4.37%		+10.07%	-6.64%

06-18	CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA	MT
06-18	CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	89,978	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-6.64%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	78,927	76,642	73,524
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-8.98%	-2.9%	-4.07%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11x	12.8x	11.7x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.1x	1.93x	1.75x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.9x	1.25x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.53x	2.56x	2.39x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.22x	2.18x	1.95x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.02x	7.75x	6.95x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	8.48x	9.96x	9.02x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	9.6x	10.9x	7.68x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	10.4%	9.16%	13%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3591	0.3662	0.3823
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.56%	4.65%	4.86%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7181	0.6164	0.6739
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50%	59.4%	56.7%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,561	35,147	37,621
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,116	9,892	10,578
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,309	7,695	8,151
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,903	6,899	7,534
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,051	-13,336	-16,454
Reference price ²	8.470	8.200	7.260	4.780	8.430	7.870	7.870	7.870
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	3/22/22	3/22/23	3/20/24	3/28/25	3/25/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.46x	2.34x	6.33x	4.36%	12B
ELI LILLY AND COMPANY	35.08x	12.75x	25.97x	0.57%	1,070B
JOHNSON & JOHNSON	27.67x	6.37x	17.29x	2.06%	624B
ABBVIE INC.	31.08x	7.52x	15.39x	2.69%	450B
ROCHE HOLDING AG	17.65x	4.4x	10.87x	3.02%	328B
NOVARTIS AG	21.61x	5.56x	13.43x	2.84%	284B
NOVO NORDISK A/S	14.17x	5.28x	10.84x	3.53%	217B
AMGEN INC.	23.97x	6.34x	11.16x	2.75%	198B
GILEAD SCIENCES, INC.	-45.95x	5.59x	31.09x	2.5%	161B
PFIZER INC.	11.55x	2.99x	7.34x	7.38%	135B
Average	14.83x	5.91x	14.97x	3.17%	347.95B
Weighted average by Cap.	23.81x	7.98x	18.26x	2.2%